Answers are grounded in this paper and cite their sources.
In vitro study demonstrates that PGC-1α suppresses insulin transcription while elevating inflammatory genes in vascular cells, suggesting a dual role in diabetes and vascular inflammation.
Background: Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α), which act as a coactivator of nuclear receptors and several other transcription factors. This study was performed to evaluate the expressional regulation of insulin and inflammatory response genes by PGC-1α. Methods: Transient transfection assays were performed to measure the promoter activity of the insulin and CXCL10 gene. The insulin gene expression levels in INS-1 cells were determined by Northern blot analysis. Differentially expressed genes by PGC-1α overexpression in HASMCs were confirmed using DNA microarray, real-time PCR and Northen blot analysis. Results: Insulin promoter activity and mRNA levels were suppressed by GR and Ad-PGC-1α. Northern blot analysis of the INS-1 cells revealed that infection with Ad-PGC-1α markedly reduced the amount of insulin mRNA and treatment of Dex enhanced this effect in an additive manner. The PGC-1α-specific siRNA decreased insulin expression that was induced by Dex in the GR-expressing INS-1 cells was nearly restored by this siRNA treatment. We found that when vascular smooth muscle cells (VSMCs) overexpressed PGC-1α, immune or inflammatory response genes were highly expressed. For example, promoter activity and mRNA level of CXCL10 gene were increased by PGC-1α. Conclusion: PGC-1α overexpression inhibited insulin promoter activity in INS-1 cells and enhanced expressions of inflammatory response genes (CXCL10, CXCL11, TNFLSF10) in VSMCs.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: